I farmaci per le malattie rare: la fortuna di essere orfani
Enrico Costa(Brigham and Women's Hospital), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Lucio Luzzatto(University of Florence), Arrigo Schieppati(Ospedale Papa Giovanni XXIII)
Cited by 6
Related Papers
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
Natural History of Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|1995|900